Could a 'Poop Pill' ease diabetic stomach pain?

NCT ID NCT06340217

Recruiting now Disease control Sponsor: The Second Hospital of Nanjing Medical University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Aug 06, 2026 · Updated 2 times

Summary

This study tests whether transferring gut bacteria from healthy donors (called washed microbiota transplantation) can help people with diabetic gastroparesis—a condition where the stomach empties too slowly, causing bloating, nausea, and fullness. Researchers will give 46 adults either the bacteria or a placebo and track symptom changes over time. The goal is to see if this approach safely reduces symptoms by at least half.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: washed microbiota transplantation (WMT) from healthy donors
What this could lead to: If it works, this could offer a new way to relieve bloating, nausea, and fullness in people with diabetic gastroparesis.
What could go wrong: This is a small, early-stage trial with only 46 participants. The placebo group may also improve, and long-term benefits or risks are unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETIC GASTROPARESIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

gastroparesis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETIC GASTROPARESIS

Contacts and locations

Locations

Department of Microbiota Medicine & Medical Centre for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University
RECRUITING

Nanjing, Jiangsu, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.